跳至主要内容
临床试验/ACTRN12605000509662
ACTRN12605000509662招募中1 期

Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer

Peter MacCallum Cancer Centre0 个研究点目标入组 30 人开始时间: 2005年9月26日最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • WHO types 2 and 3 nasopharyngeal cancer; T3-4 and/or N1 > 3 cm, N2-3; no prior malignancies, no prior chemotherapy or radiation

排除标准

  • No exclusion criteria

研究者

发起方
Peter MacCallum Cancer Centre

相似试验

已完成
2 期
Gemcitabine and cisplatin combination chemotherapy for patients with unresectable advanced and recurrent biliary tract cancernresectable and recurrent biliary tract cancer
JPRN-UMIN000007571Yokohama City University Department of Gastroenterological Surgery50
已完成
不适用
eoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancerbladder cancer
JPRN-UMIN000003146Department of Urology, Graduate School of Biomedical Sciences Hiroshima University30
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-ATniversity Medical Center Hamburg-Eppendorf440
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-ITIVERSITäTKLINIKUM HAMBURG-EPPENDORF781
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0 Level: LLT Classification code 10017620 Term: Gallbladder carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10008593 Term: Cholangiocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-DKniversity Medical Center Hamburg-Eppendorf60